Financial Statements · Financial Reporting
Aktsiaselts CHEMI-PHARM
Official identifier 10140819Record date 31 Dec 2019
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2019
- Period start
- 1 Jan 2019
- Submitted date
- 22 May 2020
Report
- Consolidated
- Yes
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Profit distribution proposal | Retained earnings (loss) from previous periods | 3,447,127 |
| Kasumi jaotamise otsus | Retained earnings (loss) from previous periods | 3,447,127 |
| Unconsolidated bilanss | Assets | 4,344,893 |
| Unconsolidated bilanss | Cash and cash equivalents | 87,387 |
| Unconsolidated bilanss | Current assets | 2,458,488 |
| Unconsolidated bilanss | Current liabilities | 584,634 |
| Unconsolidated bilanss | Equity | 3,573,760 |
| Unconsolidated bilanss | Share capital at nominal value | 25,600 |
| Unconsolidated bilanss | Non-current assets | 1,886,405 |
| Unconsolidated bilanss | Non-current liabilities | 186,499 |
| Unconsolidated bilanss | Retained earnings (loss) from previous periods | 3,284,957 |
| Unconsolidated income statement (scheme 1) | Depreciation and impairment of non-current assets | -108,448 |
| Unconsolidated income statement (scheme 1) | Labour costs | -1,587,720 |
| Unconsolidated income statement (scheme 1) | Revenue | 6,140,551 |
| Unconsolidated income statement (scheme 1) | Annual period profit / loss | 260,647 |
| Unconsolidated income statement (scheme 1) | Operating profit (loss) | 84,359 |
| Unconsolidated income statement (scheme 1) | Profit (loss) before income tax | 260,647 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 108,448 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 84,359 |
| Consolidated bilanss | Assets | 4,463,618 |
| Consolidated bilanss | Cash and cash equivalents | 110,073 |
| Consolidated bilanss | Current assets | 2,528,028 |
| Consolidated bilanss | Current liabilities | 656,879 |
| Consolidated bilanss | Equity | 3,620,240 |
| Consolidated bilanss | Share capital at nominal value | 25,600 |
| Consolidated bilanss | Non-current assets | 1,935,590 |
| Consolidated bilanss | Non-current liabilities | 186,499 |
| Consolidated bilanss | Retained earnings (loss) from previous periods | 3,447,127 |
| Consolidated income statement scheme 1 | Depreciation and impairment of non-current assets | -116,271 |
| Consolidated income statement scheme 1 | Labour costs | -1,614,131 |
| Consolidated income statement scheme 1 | Revenue | 6,859,249 |
| Consolidated income statement scheme 1 | Annual period profit / loss | 145,812 |
| Consolidated income statement scheme 1 | Profit (loss) before income tax | 146,193 |
| Consolidated income statement scheme 1 | Operating profit (loss) | 127,363 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 116,271 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 127,363 |
| Note: Labour costs | Employees | 49 |
| Note: Labour costs | Labour costs | 1,614,131 |
| Employees | 45 |
Linked company
Company: Aktsiaselts CHEMI-PHARM